These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 27406609)

  • 1. Costs and Mortality Associated With Multidrug-Resistant Healthcare-Associated Acinetobacter Infections.
    Nelson RE; Schweizer ML; Perencevich EN; Nelson SD; Khader K; Chiang HY; Chorazy ML; Blevins A; Ward MA; Samore MH
    Infect Control Hosp Epidemiol; 2016 Oct; 37(10):1212-8. PubMed ID: 27406609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia.
    Lee NY; Lee HC; Ko NY; Chang CM; Shih HI; Wu CJ; Ko WC
    Infect Control Hosp Epidemiol; 2007 Jun; 28(6):713-9. PubMed ID: 17520546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Systematic Review of the Burden of Multidrug-Resistant Healthcare-Associated Infections Among Intensive Care Unit Patients in Southeast Asia: The Rise of Multidrug-Resistant Acinetobacter baumannii.
    Teerawattanapong N; Panich P; Kulpokin D; Na Ranong S; Kongpakwattana K; Saksinanon A; Goh BH; Lee LH; Apisarnthanarak A; Chaiyakunapruk N
    Infect Control Hosp Epidemiol; 2018 May; 39(5):525-533. PubMed ID: 29580299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The healthcare costs of antimicrobial resistance in Lebanon: a multi-centre prospective cohort study from the payer perspective.
    Iskandar K; Roques C; Hallit S; Husni-Samaha R; Dirani N; Rizk R; Abdo R; Yared Y; Matta M; Mostafa I; Matta R; Salameh P; Molinier L
    BMC Infect Dis; 2021 May; 21(1):404. PubMed ID: 33933013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attributable Mortality of Healthcare-Associated Infections Due to Multidrug-Resistant Gram-Negative Bacteria and Methicillin-Resistant Staphylococcus Aureus.
    Nelson RE; Slayton RB; Stevens VW; Jones MM; Khader K; Rubin MA; Jernigan JA; Samore MH
    Infect Control Hosp Epidemiol; 2017 Jul; 38(7):848-856. PubMed ID: 28566096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality rates associated with multidrug-resistant Acinetobacter baumannii infection in surgical intensive care units.
    Daniels TL; Deppen S; Arbogast PG; Griffin MR; Schaffner W; Talbot TR
    Infect Control Hosp Epidemiol; 2008 Nov; 29(11):1080-3. PubMed ID: 18837670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of carbapenem resistance on clinical and economic outcomes among patients with Acinetobacter baumannii infection in Colombia.
    Lemos EV; de la Hoz FP; Alvis N; Einarson TR; Quevedo E; Castañeda C; Leon Y; Amado C; Cañon O; Kawai K
    Clin Microbiol Infect; 2014 Feb; 20(2):174-80. PubMed ID: 23668595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality, Length of Stay, and Healthcare Costs Associated With Multidrug-Resistant Bacterial Infections Among Elderly Hospitalized Patients in the United States.
    Nelson RE; Hyun D; Jezek A; Samore MH
    Clin Infect Dis; 2022 Mar; 74(6):1070-1080. PubMed ID: 34617118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing Time-dependent Bias in Estimates of the Attributable Cost of Health Care-associated Methicillin-resistant Staphylococcus aureus Infections: A Comparison of Three Estimation Strategies.
    Nelson RE; Samore MH; Jones M; Greene T; Stevens VW; Liu CF; Graves N; Evans MF; Rubin MA
    Med Care; 2015 Sep; 53(9):827-34. PubMed ID: 26225444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healthcare-Associated Infections Due to Multidrug-Resistant Organisms: a Surveillance Study on Extra Hospital Stay and Direct Costs.
    Giraldi G; Montesano M; Napoli C; Frati P; La Russa R; Santurro A; Scopetti M; Orsi GB
    Curr Pharm Biotechnol; 2019; 20(8):643-652. PubMed ID: 30961489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct costs of multidrug-resistant Acinetobacter baumannii in the burn unit of a public teaching hospital.
    Wilson SJ; Knipe CJ; Zieger MJ; Gabehart KM; Goodman JE; Volk HM; Sood R
    Am J Infect Control; 2004 Oct; 32(6):342-4. PubMed ID: 15454892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Burden of meticillin-resistant Staphylococcus aureus infections at a Swiss University hospital: excess length of stay and costs.
    Macedo-Viñas M; De Angelis G; Rohner P; Safran E; Stewardson A; Fankhauser C; Schrenzel J; Pittet D; Harbarth S
    J Hosp Infect; 2013 Jun; 84(2):132-7. PubMed ID: 23608003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiologic, clinical, and economic evaluation of an outbreak of clonal multidrug-resistant Acinetobacter baumannii infection in a surgical intensive care unit.
    Young LS; Sabel AL; Price CS
    Infect Control Hosp Epidemiol; 2007 Nov; 28(11):1247-54. PubMed ID: 17926275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs attributable to healthcare-acquired infection in hospitalized adults and a comparison of economic methods.
    Roberts RR; Scott RD; Hota B; Kampe LM; Abbasi F; Schabowski S; Ahmad I; Ciavarella GG; Cordell R; Solomon SL; Hagtvedt R; Weinstein RA
    Med Care; 2010 Nov; 48(11):1026-35. PubMed ID: 20940650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospital-acquired infections in Belgian acute-care hospitals: an estimation of their global impact on mortality, length of stay and healthcare costs.
    Vrijens F; Hulstaert F; Devriese S; van de Sande S
    Epidemiol Infect; 2012 Jan; 140(1):126-36. PubMed ID: 21320376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hospital-acquired infections in Belgian acute-care hospitals: financial burden of disease and potential cost savings.
    Trybou J; Spaepen E; Vermeulen B; Porrez L; Annemans L
    Acta Clin Belg; 2013; 68(3):199-205. PubMed ID: 24156220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and impact of imipenem resistance in Acinetobacter baumannii.
    Lautenbach E; Synnestvedt M; Weiner MG; Bilker WB; Vo L; Schein J; Kim M
    Infect Control Hosp Epidemiol; 2009 Dec; 30(12):1186-92. PubMed ID: 19860563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk and Prognostic Factors for Multidrug-Resistant Acinetobacter Baumannii Complex Bacteremia: A Retrospective Study in a Tertiary Hospital of West China.
    Liu Q; Li W; Du X; Li W; Zhong T; Tang Y; Feng Y; Tao C; Xie Y
    PLoS One; 2015; 10(6):e0130701. PubMed ID: 26083415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Magnitude of Time-Dependent Bias in the Estimation of Excess Length of Stay Attributable to Healthcare-Associated Infections.
    Nelson RE; Nelson SD; Khader K; Perencevich EL; Schweizer ML; Rubin MA; Graves N; Harbarth S; Stevens VW; Samore MH
    Infect Control Hosp Epidemiol; 2015 Sep; 36(9):1089-94. PubMed ID: 26041436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of multi-drug resistant bacteria on economic and clinical outcomes of healthcare-associated infections in adults: Systematic review and meta-analysis.
    Serra-Burriel M; Keys M; Campillo-Artero C; Agodi A; Barchitta M; Gikas A; Palos C; López-Casasnovas G
    PLoS One; 2020; 15(1):e0227139. PubMed ID: 31923281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.